One dramatically up-regulated protein S100A9 (ratio = 19) was further validated by ELISA in sera from liver cirrhosis (LC, HCC high risk population) and HCC patients (n = 47 for each group). This evidence concerns the gene S100A9 and laryngotracheoesophageal cleft.